SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001564590-22-029990
Filing Date
2022-08-23
Accepted
2022-08-23 17:00:51
Documents
1
Effectiveness Date
2022-08-23

Document Format Files

Seq Description Document Type Size
1 S-8 POS 333-214722 ljpc-s8pos.htm S-8 POS 38632
  Complete submission text file 0001564590-22-029990.txt   39637
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-214722 | Film No.: 221188194
SIC: 2836 Biological Products, (No Diagnostic Substances)